Lenalidomide as potential treatment in small cell neuroendocrine lung cancer with del 5q
<p>Lung cancer is a leading cause of cancer deaths world-wide, with the carcinogens in tobacco smoke playing a major etiologic role. Genetic changes responsible for carcinogenesis include activation of proto-oncogenes and inactivation of tumor suppressor genes. Tumor suppressor gene inactivati...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Scientific Journal of Genetics and Gene Therapy - Peertechz Publications,
2018-07-11.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_sjggt_000014 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Paul Hartel |e author |
| 245 | 0 | 0 | |a Lenalidomide as potential treatment in small cell neuroendocrine lung cancer with del 5q |
| 260 | |b Scientific Journal of Genetics and Gene Therapy - Peertechz Publications, |c 2018-07-11. | ||
| 520 | |a <p>Lung cancer is a leading cause of cancer deaths world-wide, with the carcinogens in tobacco smoke playing a major etiologic role. Genetic changes responsible for carcinogenesis include activation of proto-oncogenes and inactivation of tumor suppressor genes. Tumor suppressor gene inactivation is contributed to, in part, by loss of chromosomal DNA. While cytogenetic findings in small cell neuroendocrine lung carcinoma are complex, 5q deletion is among the most frequently identified [1,2].</p> | ||
| 540 | |a Copyright © Paul Hartel et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Mini Review |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/sjggt.000014 |z Connect to this object online. |